These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

685 related items for PubMed ID: 20085803

  • 1. Effect of carrier morphology and surface characteristics on the development of respirable PLGA microcapsules for sustained-release pulmonary delivery of insulin.
    Hamishehkar H, Emami J, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H, Nokhodchi A.
    Int J Pharm; 2010 Apr 15; 389(1-2):74-85. PubMed ID: 20085803
    [Abstract] [Full Text] [Related]

  • 2. Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method.
    You Y, Zhao M, Liu G, Tang X.
    J Pharm Pharmacol; 2007 Jul 15; 59(7):927-34. PubMed ID: 17637186
    [Abstract] [Full Text] [Related]

  • 3. Preparation and evaluation of poly(lactic-co-glycolic acid) microparticles as a carrier for pulmonary delivery of recombinant human interleukin-2: II. In vitro studies on aerodynamic properties of dry powder inhaler formulations.
    Devrim B, Bozkır A, Canefe K.
    Drug Dev Ind Pharm; 2011 Nov 15; 37(11):1376-86. PubMed ID: 21548727
    [Abstract] [Full Text] [Related]

  • 4. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
    Ungaro F, d'Emmanuele di Villa Bianca R, Giovino C, Miro A, Sorrentino R, Quaglia F, La Rotonda MI.
    J Control Release; 2009 Apr 02; 135(1):25-34. PubMed ID: 19154761
    [Abstract] [Full Text] [Related]

  • 5. Adhesion and redistribution of salmeterol xinafoate particles in sugar-based mixtures for inhalation.
    Adi H, Larson I, Stewart PJ.
    Int J Pharm; 2007 Jun 07; 337(1-2):229-38. PubMed ID: 17303354
    [Abstract] [Full Text] [Related]

  • 6. Dry powder inhalers: physicochemical and aerosolization properties of several size-fractions of a promising alterative carrier, freeze-dried mannitol.
    Kaialy W, Nokhodchi A.
    Eur J Pharm Sci; 2015 Feb 20; 68():56-67. PubMed ID: 25497318
    [Abstract] [Full Text] [Related]

  • 7. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM, MacRitchie HB, Marriott C, Martin GP.
    Int J Pharm; 2007 Mar 21; 333(1-2):45-55. PubMed ID: 17064863
    [Abstract] [Full Text] [Related]

  • 8. Aerosolization properties, surface composition and physical state of spray-dried protein powders.
    Bosquillon C, Rouxhet PG, Ahimou F, Simon D, Culot C, Préat V, Vanbever R.
    J Control Release; 2004 Oct 19; 99(3):357-67. PubMed ID: 15451594
    [Abstract] [Full Text] [Related]

  • 9. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
    Ohashi K, Kabasawa T, Ozeki T, Okada H.
    J Control Release; 2009 Apr 02; 135(1):19-24. PubMed ID: 19121349
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics and pharmacodynamics of controlled release insulin loaded PLGA microcapsules using dry powder inhaler in diabetic rats.
    Hamishehkar H, Emami J, Najafabadi AR, Gilani K, Minaiyan M, Hassanzadeh K, Mahdavi H, Koohsoltani M, Nokhodchi A.
    Biopharm Drug Dispos; 2010 Mar 02; 31(2-3):189-201. PubMed ID: 20238376
    [Abstract] [Full Text] [Related]

  • 11. The enhanced aerosol performance of salbutamol from dry powders containing engineered mannitol as excipient.
    Kaialy W, Martin GP, Ticehurst MD, Momin MN, Nokhodchi A.
    Int J Pharm; 2010 Jun 15; 392(1-2):178-88. PubMed ID: 20363301
    [Abstract] [Full Text] [Related]

  • 12. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.
    Cheow WS, Ng ML, Kho K, Hadinoto K.
    Int J Pharm; 2011 Feb 14; 404(1-2):289-300. PubMed ID: 21093560
    [Abstract] [Full Text] [Related]

  • 13. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C, MacRitchie HB, Zeng XM, Martin GP.
    Int J Pharm; 2006 Dec 01; 326(1-2):39-49. PubMed ID: 16942848
    [Abstract] [Full Text] [Related]

  • 14. Powder properties and their influence on dry powder inhaler delivery of an antitubercular drug.
    Sethuraman VV, Hickey AJ.
    AAPS PharmSciTech; 2002 Dec 01; 3(4):E28. PubMed ID: 12916922
    [Abstract] [Full Text] [Related]

  • 15. A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid-polymer hybrid nanoparticles.
    Wang Y, Kho K, Cheow WS, Hadinoto K.
    Int J Pharm; 2012 Mar 15; 424(1-2):98-106. PubMed ID: 22226876
    [Abstract] [Full Text] [Related]

  • 16. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients.
    Minne A, Boireau H, Horta MJ, Vanbever R.
    Eur J Pharm Biopharm; 2008 Nov 15; 70(3):839-44. PubMed ID: 18620052
    [Abstract] [Full Text] [Related]

  • 17. Simple and scalable method for peptide inhalable powder production.
    Schoubben A, Blasi P, Giovagnoli S, Ricci M, Rossi C.
    Eur J Pharm Sci; 2010 Jan 31; 39(1-3):53-8. PubMed ID: 19879945
    [Abstract] [Full Text] [Related]

  • 18. Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease.
    Adi H, Young PM, Chan HK, Agus H, Traini D.
    Eur J Pharm Sci; 2010 Jun 14; 40(3):239-47. PubMed ID: 20371286
    [Abstract] [Full Text] [Related]

  • 19. Spray dried mannitol carrier particles with tailored surface properties--the influence of carrier surface roughness and shape.
    Littringer EM, Mescher A, Schroettner H, Achelis L, Walzel P, Urbanetz NA.
    Eur J Pharm Biopharm; 2012 Sep 14; 82(1):194-204. PubMed ID: 22595133
    [Abstract] [Full Text] [Related]

  • 20. Preparation and characterization of spray-dried powders intended for pulmonary delivery of insulin with regard to the selection of excipients.
    Razavi Rohani SS, Abnous K, Tafaghodi M.
    Int J Pharm; 2014 Apr 25; 465(1-2):464-78. PubMed ID: 24560646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.